Kidney Stones for NEET PG 2027: Stone Composition, ESWL, URS, PCNL | NEETPGAI
nephrolithiasiskidney stonesESWLPCNLurologyNEET PG 2027stone belt
Kidney Stones for NEET PG 2027: Stone Composition, ESWL, URS, PCNL
Master nephrolithiasis for NEET PG 2027 — stone composition (calcium oxalate, struvite, uric acid, cystine), CT KUB diagnosis, medical expulsive therapy, and ESWL vs URS vs PCNL choice.
Dr. NEETPGAI Editorial TeamPublished 18 Oct 202610 min read
Share this article
Ready to put this into practice?
Start practicing NEET PG MCQs with AI-powered explanations.
Nephrolithiasis is a NEET PG staple across Surgery, Medicine, and Radiology. India's northern "stone belt" makes it particularly high-yield. The framework:
Imaging — non-contrast CT KUB is gold standard; ultrasound in pregnancy and children.
Acute management — NSAIDs first-line for pain, hydration, alpha-blocker for distal ureteric stones 5 to 10 mm (MET).
Definitive treatment — ESWL for less than 2 cm renal or proximal ureteric; URS for mid and distal ureteric; PCNL for over 2 cm or staghorn.
Urgent drainage — fever, sepsis, obstructed solitary kidney, AKI — ureteric stent or PCN emergency.
Prevention — hydration above 2 L/day, dietary changes, and targeted therapy after 24-hour urine analysis for recurrent formers.
The Indian stone belt (Uttar Pradesh, Rajasthan, Gujarat, Punjab, Haryana) has some of the world's highest nephrolithiasis prevalence, driven by hot climate, hard water, dietary patterns, and dehydration. NEET PG has responded by testing stone composition, CT KUB interpretation, MET criteria, and the ESWL versus URS versus PCNL choice as recurring themes.
This NEETPGAI deep dive covers epidemiology, stone composition, risk factors, clinical presentation, imaging, acute and definitive management, prevention strategies for recurrent formers, and India-specific programme considerations. Pair it with the Surgery subject hub and the urinary tract infection guide.
Epidemiology
Lifetime prevalence 10 to 15 percent globally.
India — highest prevalence in the northern "stone belt" states.
Male to female ratio 2 to 1.
Peak incidence 30 to 50 years.
Recurrence 50 percent within 10 years without preventive therapy.
Classic ureteric colic — sudden onset severe unilateral flank pain radiating to groin (loin to groin), waxing and waning, associated with nausea, vomiting, and restlessness (unlike peritonitis where patients lie still). Additional features:
Haematuria — micro or macroscopic.
Dysuria and urinary frequency if stone at vesicoureteric junction.
Fever and rigors suggest obstructed infected stone — urological emergency.
Referred testicular or labial pain from lower ureteric stone.
Diagnosis
Urinalysis
Blood — micro or macroscopic haematuria in 85 percent (absent in 15 percent, especially with complete obstruction).
Non-contrast CT KUB — gold standard; sensitivity and specificity above 95 percent for stones. Gives size, location, Hounsfield density (below 900 HU predicts ESWL success), skin-to-stone distance, and alternative diagnoses.
Ultrasound — first-line in pregnancy and children; sensitive for hydronephrosis and renal stones; poor for mid-ureteric stones.
Plain KUB X-ray — visualises radio-opaque stones (calcium, struvite, cystine); misses radiolucent (uric acid, indinavir); useful for follow-up if stone visible.
IVP (intravenous pyelogram) — largely obsolete; replaced by CT.
CT with contrast or MR urography — anatomical planning for complex cases.
Stone analysis (if retrieved) — definitive composition guides prevention.
Acute management
Pain and expulsion
NSAIDs — ketorolac IV or diclofenac IM first-line; superior to opioids and reduce ureteric smooth muscle contraction.
Opioids — reserve for NSAID contraindication or inadequate relief.
Anti-emetics — ondansetron or metoclopramide.
Hydration — oral or IV to maintain urine output; excessive fluids do not accelerate passage.
Medical expulsive therapy (MET) — alpha-blocker (tamsulosin 0.4 mg daily, silodosin) for distal ureteric stones 5 to 10 mm without complications; increases passage rate and reduces time to passage.
Best for — renal stones over 2 cm, staghorn calculi, complex anatomy (horseshoe kidney, calyceal diverticula), ESWL and URS failure.
Mechanism — percutaneous tract into the renal collecting system through the posterior calyx; nephroscope with ultrasonic, pneumatic, or laser lithotripter for fragmentation.
Success rate — 85 to 95 percent stone-free after single procedure.
Complications — significant bleeding (transfusion in 5 to 10 percent, embolisation in less than 1 percent), pneumothorax and hydrothorax (supracostal punctures), sepsis, injury to adjacent organs.
Open and robot-assisted surgery
Reserved for anatomic anomalies (ureteropelvic junction obstruction plus stones), failed minimally invasive approaches, or when combined reconstruction is needed. Increasingly rare in modern practice.
Struvite stones — special considerations
Form only with urease-producing bacteria that alkalinise urine and generate ammonium.
Rapid growth into staghorn calculi filling the collecting system.
Management principles — complete stone removal (usually PCNL), culture-directed antibiotics 4 to 6 weeks after clearance, urease inhibitor acetohydroxamic acid in select recurrent cases, and long-term surveillance imaging to detect regrowth.
Never leave residual struvite fragments — they act as infection nidus.
Prevention (recurrent stone formers, defined as two or more lifetime stones)
Universal advice
Hydration — urine output above 2 to 2.5 L/day; drink water above 3 L in hot climate.
Reduce dietary sodium (under 2.3 g/day) to lower urinary calcium.
Moderate animal protein.
Adequate dietary calcium (800 to 1200 mg/day) from food — calcium binds oxalate in the gut; do not restrict.
Avoid calcium supplements (increase risk); if used, take with meals.
Reduce high-oxalate foods (spinach, rhubarb, nuts, chocolate, tea, beets) in oxalate stone formers.
Increase citrus intake and dietary potassium.
Targeted therapy (based on 24-hour urine)
Abnormality
Therapy
Hypercalciuria
Thiazide diuretic (hydrochlorothiazide or chlorthalidone)
Hypocitraturia
Potassium citrate
Hyperuricosuria
Allopurinol; alkalinise urine with potassium citrate for pure uric acid stones
Hyperoxaluria (enteric)
Calcium citrate with meals, low fat diet
Cystinuria
Alkalinisation to pH above 7.5, tiopronin or D-penicillamine, high fluid intake
Primary hyperparathyroidism
Parathyroidectomy
NEET PG MCQ traps
CT KUB is non-contrast — a contrast CT is not first-line for renal colic and masks stones.
MET is for distal ureteric stones 5 to 10 mm — not proximal; alpha-blocker (tamsulosin).
Struvite stones need urease-producing bacteria — Proteus is the classic; not E. coli.
Uric acid stones are radiolucent on plain X-ray — visible on CT.
Do not restrict dietary calcium for calcium oxalate stone formers — this increases risk.
Obstructed infected stone is a urological emergency — drainage first (stent or PCN), definitive stone treatment later.
ESWL is contraindicated in pregnancy — use URS or observation.
PCNL is first-line for staghorn calculi, not ESWL.
Cystine crystals are hexagonal — pathognomonic on urinalysis.
Indian context
Stone belt — Uttar Pradesh, Rajasthan, Gujarat, Punjab, Haryana; hot summers, hard water, low fluid intake, and vegetarian oxalate load.
PMJAY urology coverage — most stone procedures (ESWL, URS, PCNL) are covered under Ayushman Bharat state packages.
Cost declines — holmium laser and low-cost ESWL machines are increasingly available in tier-2 city hospitals.
Public health outreach — stone-belt medical camps focus on hydration awareness, especially during summer months.
Paediatric stones — India has one of the higher paediatric nephrolithiasis burdens, often metabolic or infection-related; always evaluate for hypercalciuria and hyperoxaluria.
Endemic bladder stones — historically prevalent among children in low-protein-diet regions; declining with improved nutrition.
Frequently asked questions
What is the imaging modality of choice for suspected renal colic?
Non-contrast CT KUB is the gold standard for renal colic. It has above 95 percent sensitivity and specificity for stones, gives stone size, location, and Hounsfield density (guides ESWL success), and identifies alternative diagnoses. Ultrasound is preferred in pregnancy and children and in follow-up. Intravenous pyelography (IVP) is largely obsolete.
When is medical expulsive therapy indicated for ureteric stones?
Medical expulsive therapy with alpha-blockers (tamsulosin 0.4 mg daily or silodosin) is recommended for distal ureteric stones 5 to 10 mm without infection, sepsis, uncontrolled pain, or acute renal failure. Stones under 5 mm pass spontaneously in around 90 percent of cases with hydration and analgesia. Stones over 10 mm are unlikely to pass and usually need intervention.
What is the treatment of choice for large staghorn calculi?
Percutaneous nephrolithotomy (PCNL) is the treatment of choice for renal stones over 2 cm and staghorn calculi. Complete stone clearance is essential, especially for infection stones (struvite), because residual fragments serve as a nidus for recurrent infection and stone growth. Multiple PCNL tracts or combined approaches (ECIRS — endoscopic combined intrarenal surgery) may be needed.
How are struvite stones different from calcium oxalate stones?
Struvite (magnesium ammonium phosphate) stones form only in the presence of urease-producing organisms (Proteus, Klebsiella, Pseudomonas, Staphylococcus saprophyticus) that raise urinary pH above 7 and generate ammonium. They grow rapidly, often as staghorn calculi filling the collecting system, and require complete stone removal, prolonged culture-directed antibiotics, and sometimes acetohydroxamic acid urease inhibition to prevent recurrence.
What are the long-term prevention strategies for recurrent stone formers?
For patients with two or more lifetime stones, a 24-hour urine analysis guides therapy. Universal advice includes hydration above 2 to 3 litres per day, reduced dietary sodium, moderate animal protein, adequate dietary calcium (not supplements), and reduced high-oxalate foods. Targeted therapies include potassium citrate for hypocitraturia, thiazide diuretics for hypercalciuria, and allopurinol for hyperuricosuria.
This content is for educational purposes for NEET PG exam preparation. It is not a substitute for professional medical advice, diagnosis, or treatment. Clinical information has been reviewed by qualified medical professionals.
Written by: NEETPGAI Editorial Team
Reviewed by: Pending SME Review
Last reviewed: September 2026
